Indaptus Therapeutics, Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
0 sales (0 not pre-planned) · 0 purchases
No insider sales or purchases in the last 6 months.
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
- Other newsNews report (8-K)Oct 20, 2026
- Signed a major agreementNews report (8-K)Sep 30, 2026
- Signed a major agreementNews report (8-K)Sep 10, 2026
- Signed a major agreementCorrection to a news report (8-K/A)Sep 8, 2026
- New shares being soldNew shares being sold (424B5)Sep 4, 2026
- An executive or board member joined or leftNews report (8-K)Sep 4, 2026
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.